Bill
Bill > A05029
NY A05029
NY A05029Relates to the substitution of brand name epinephrine auto-injectors with alternate epinephrine auto-injectors in certain cases.
summary
Introduced
02/11/2025
02/11/2025
In Committee
01/07/2026
01/07/2026
Crossed Over
Passed
Dead
Introduced Session
2025-2026 General Assembly
Bill Summary
AN ACT to amend the education law, in relation to the substitution of brand name epinephrine auto-injectors with alternate epinephrine autoinjectors for dispensation by pharmacists
AI Summary
This bill amends the New York education law to allow pharmacists to substitute a brand name epinephrine auto-injector with an alternate epinephrine auto-injector under specific conditions. The pharmacist can make this substitution if: the prescriber has not specified that the prescription must be dispensed exactly as written, the alternate auto-injector is available at a lower cost to the patient, the pharmacist has advised the patient or their representative about the alternate option and received their consent, and the pharmacist has provided counseling on how to properly use the alternate device. An epinephrine auto-injector is a medical device used to quickly deliver a dose of epinephrine (adrenaline) during a severe allergic reaction, with the most well-known brand being EpiPen. The bill aims to provide patients with more affordable options for this critical medical device while ensuring patient safety through informed consent and professional guidance. The law would take effect immediately upon passage.
Committee Categories
Education
Sponsors (1)
Last Action
referred to higher education (on 01/07/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.nysenate.gov/legislation/bills/2025/A5029 |
| BillText | https://assembly.state.ny.us/leg/?default_fld=&bn=A05029&term=2025&Summary=Y&Actions=Y&Text=Y&Committee%26nbspVotes=Y&Floor%26nbspVotes=Y#A05029 |
Loading...